www.StockMarketingInc.com: Two Incedible Stories!! (FORC) Force Energy Corp. Announces $5 Million Equity Financing!! & (UNDT) North Korea Has Stockpiles of Biological Weapons According to Report

Oct 8, 2009 -- STOCK MARKETING INC PRESENTS :

(OTCBB: FORC) Force Energy Corp.

(OTCBB: UNDT) Universal Detection Technology

(NASDAQ: HLCS) Helicos BioSciences Corp.

(OTCBB: NTRO) Nitro Petroleum, Inc.

(NASDAQ: XOM) Exxon Mobil Corp.

(NYSE: NOC) Northrop Grumman Corp.

www.StockMarketingInc.com

To sign up for our free Profiles & Alerts :: visit

http://www.StockMarketingInc.com

Email us!! info@StockMarketingInc.com OR CALL 1-866-583-8960 ----------------------------------------------------------------- ----------------------------------------------------------------- --------------------------

(OTCBB: FORC) Force Energy Corp.

BREAKING NEWS!!

Force Energy Corp. Announces $5 Million Equity Financing

DENVER, COLORADO, Oct 7, 2009 -- Force Energy Corp. (OTCBB:FORC) (FRANKFURT:FC2) (hereafter "Force", "the Company"), is pleased to announce that the company has entered into a financing agreement with Banque SCS Alliance, whereby the Swiss based banking group will invest up to $5 million into Force Energy Corp.

The financing agreement is equity based and market condition dependent. The agreement may be receded by either party with 30 days notice. Funds will be used to advance drilling activities on the Diamond Springs Prospect as well as for general working capital and investment purposes. Force Energy has secured only traditional equity financing.

"We are pleased to have Bank SCS Alliance in our corner." Said Rahim Rayani, President & CEO of Force Energy Corp. "This financing agreement will allow the Company to execute on our plans to explore and develop the Diamond Springs Prospect."

The securities offered have not been registered under the Securities Act of 1933 and may not be offered or sold in the United States absent a registration or an applicable exemption from the registration requirements.

About Force Energy Corp.

Force Energy Corp. is an Oil & Gas Exploration and Development Company based in Denver, CO with a focus on Wyoming. Using a geology-based methodology, the US Geological Survey estimate a mean of 2.4 trillion cubic feet of undiscovered natural gas and a mean of 41 million barrels of undiscovered oil in the Wind River Basin Province of Wyoming. Force Energy Corp. has acquired 75% working interest in the Diamond Springs Prospect located within this prolific area. The Company's shares are publicly traded on the OTCBB under the ticker symbol FORC.

On behalf of the Board of Directors

FORCE ENERGY CORP.

Legal Notice Regarding Forward-Looking Statements

Legal Notice Regarding Forward-Looking Statements in this news release that are not historical facts are forward-looking statements that are subject to risks and uncertainties. Forward- looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined, and assumptions of management. Forward looking statements are generally, but not always, identified by the words "expects", "plans", "anticipates", "has", "believes", "intends", "estimates", "projects", "aims", "potential", "goal", "objective", "prospective", and similar expressions or that events or conditions "will", "would", "may", "can", "could" or "should" occur. Information concerning oil or natural gas reserve estimates may also be deemed to be forward looking statements, as it constitutes a prediction of what might be found to be present when and if a project is actually developed.

Actual results may differ materially from those currently anticipated due to a number of factors beyond the reasonable control of the Company. It is important to note that actual outcomes and the Company's actual results could differ materially from those in such forward-looking statements. Factors that could cause actual results to differ materially include misinterpretation of data, inaccurate estimates of oil and natural gas reserves, the uncertainty of the requirements demanded by environmental agencies, the Company's ability to raise financing for operations, breach by parties with whom we have contracted, inability to maintain qualified employees or consultants because of compensation or other issues, competition for equipment, inability to obtain drilling permits, potential delays or obstacles in drilling operations and interpreting data, the likelihood that no commercial quantities of oil or gas are found or recoverable, and our ability to participate in the exploration of, and successful completion of development programs on all aforementioned prospects and leases. Additional information on risks for the Company can be found in filings on Edgar of other junior oil and gas exploration companies with the US Securities and Exchange Commission.

SOURCE: Force Energy Corp.

CONTACT: Investor Relations Force Energy Corp.

Rahim Rayani, President & CEO 1-866-953-FORC (3672) ir@forceenergycorp.com www.forceenergycorp.com

----------------------------------------------------------------- ----------------------------------------------------------------- --------------------------

(OTCBB: UNDT) Universal Detection Technology

BREAKING NEWS!!

North Korea Has Stockpiles of Biological Weapons According to Report; Universal Detection Technology to Be Selected by U.S. Department of Commerce to Prepare South Korea In Response to a South Korean Defense Ministry Report on the North Korean Bio-Threat, UNDT to Become Featured U.S. Exporter of Bioterrorism Equipment to South Korea

LOS ANGELES, CA, Oct 07, 2009 -- Universal Detection Technology (www.udetection.com) (OTCBB: UNDT), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, announced today that it will become a featured exporter of biological weapon detection equipment in South Korea. The U.S. Department of Commerce's Commercial Service will assist UNDT in the listing. According to a South Korean defense ministry report issued yesterday, the North Korean regime is capable of unleashing 13 types of lethal biological agents.

In one of the most detailed assessments of the dictatorship's biological weapons arsenal, the report said that North Korea has the ability to launch as many as 13 kinds of viral and bacterial attacks. In a submission to the South Korean National Assembly, the defense minister also said that the North has 5,000 tons of chemical weapons, believed to include mustard gas, phosgene and sarin. Among its biological agents are anthrax, cholera, yellow fever, smallpox, typhus, typhoid fever and dysentery.

Universal Detection Technology's 5-agent Bioterrorism detection kits, the premier product available under the agreement, have been extensively used by first responders and private industry throughout the United States. Testing of the kits by the U.S. DOD, as well as the United Kingdom military, show that the kits demonstrate no cross-reactivity with near neighbor species and no false positives with commonly encountered "white powders." The kits are designed to test for anthrax, botulinum toxin, Ricin, plague (Y. Pestis) and SEBs in as little as three minutes.

For more information please visit www.udetection.com or email

info@udetection.com.

About Universal Detection Technology

Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The company, on its own and with development partners, is positioned to capitalize on opportunities related to Homeland Security. For example, Universal Detection Technology, in cooperation with NASA, has developed a bacterial spore detector that detects certain biohazard substances. The company is also a reseller of handheld assays used for detection of five bioterrorism agents, radiation detection systems and antimicrobial products. www.udetection.com.

Forward-Looking Statements

Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.

Media Contact(s): Stefan Pollack Jonathan Younger The Pollack PR Marketing Group 310-556-4443 Email Contact Email Contact

Company Contact: Jacques Tizabi 310-248-3655 Email Contact

----------------------------------------------------------------- ----------------------------------------------------------------- --------------------------

(NASDAQ: HLCS) Helicos BioSciences Corp.

BREAKING NEWS!!

Helicos BioSciences Receives $1000 Genome Award

NHGRI's "$1000 Genome Sequencing Technology Development" Program supports Helicos' technology initiatives

CAMBRIDGE, Mass., Oct 08, 2009 -- Helicos BioSciences Corporation (NASDAQ: HLCS) announced today that it is the recipient of an award from the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH). The two year grant, totaling $2.9 Million, is part of the Sequencing Technology Development Program representing NHGRI's Signature Project for the American Recovery and Reinvestment Act's effort to jumpstart the economy and create or save millions of jobs. This project, a part of NIH's "Grand Opportunities" program, is designed to support large-scale, high impact research projects that are expected to accelerate critical scientific breakthroughs and enable growth and investment in biomedical research and development.

"This grant will fund research on the chemistry and molecular biology underlying the Helicos System. We expect to make continuous improvements to the core technology that will increase throughput and accuracy of the System without any hardware changes," stated John Thompson, Principal Investigator for the grant. "We believe that lower cost sequencing will lead to a better understanding of the biological mechanisms underlying disease states, and ultimately aid in identifying new ways to diagnose, treat and prevent human disease. We see a future in which all scientists, physicians, and patients will be able to benefit from readily available human genome sequences."

The Helicos(R) Genetic Analysis System is the world's first and only commercially available, single molecule sequencing technology. It enables scientists to conduct revolutionary studies in the fields of genome biology, cancer research, common diseases, and microbiology without DNA ligation or amplification. Genetic analysis with Helicos' technology eliminates the biases, complexity and errors introduced by nucleic acid amplification, requires minute amounts of starting material, and provides the most direct and accurate view of the genome.

"New as well as existing customers who have already purchased a Helicos System will be able to take advantage of the future versions of single molecule chemistry to generate more sequence data with the same hardware. Customers are already benefitting from the throughput, simple sample preparation protocols and low sample input requirements that our single molecule technology allows," described Ron Lowy, CEO of Helicos. "NHGRI's leadership role in stimulating research in sequencing technology has helped to accelerate progress, and we are proud to be recipients of this award."

About Helicos BioSciences:

Helicos BioSciences is a life science company focused on innovative genetic analysis technologies for the research, drug discovery, and diagnostic markets. Helicos' proprietary True Single Molecule Sequencing, tSMS(TM), technology allows direct measurement of billions of strands of DNA enabling scientists to perform experiments and ask questions never before possible. Helicos is a recipient of two $1,000 genome grants and committed to providing scientists the tools to unlock the era of genomic medicine. The company's corporate headquarters are located at One Kendall Square, Building 700, Cambridge, MA 02139, and its telephone number is (617) 264-1800. For more information, please visit www.helicosbio.com Certain statements made in this press release that are not based on historical information are forward-looking statements which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. This press release contains express or implied forward-looking statements relating to the commercial and scientific outcome of the research and technology optimization initiatives discussed in this press release, and management's plans, objectives and strategies. These statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond Helicos' control, which could cause actual results to differ materially from those contemplated in these forward-looking statements. In particular, the risks and uncertainties include, among other things, our ability to successfully complete and/or scale the manufacturing and commercialization process for the Helicos Genetic Analysis System; our history of operating losses and ability to achieve profitability; our ability to sustain and scale our manufacturing capabilities; the research and development spending levels of academic, clinical and governmental research institutions and pharmaceutical, biotechnology and agriculture companies who may purchase our Helicos Genetic Analysis System; our reliance on third-party suppliers; competition; changing technology and customer requirements; our ability to operate in an emerging market; market acceptance of our technology; the length of our sales and implementation cycles; our dependence on large contracts for the sale and implementation of our Helicos Genetic Analysis System; failure of our technology and products; our ability to maintain customer relationships and contracts; ethical, legal and social concerns surrounding the use of genetic information; our ability to retain our personnel and hire additional skilled personnel; our ability to manage our growth while operating with limited resources; our ability to control our operating expenses; general economic and business conditions; our ability to obtain capital when desired on favorable terms; and the volatility of the market price of our common stock. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Helicos undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise. For additional disclosure regarding these and other risks faced by Helicos, see the disclosure contained in Helicos' public filings with the Securities and Exchange Commission.

SOURCE: Helicos BioSciences Corporation

----------------------------------------------------------------- ----------------------------------------------------------------- --------------------------

(OTCBB: NTRO) Nitro Petroleum, Inc.

BREAKING NEWS!!

Nitro Petroleum Inc announces resignation of president, Larry Wise

Oct 08, 2009 -- The board of directors of Nitro Petroleum Inc (OTCBB:NTRO), an energy company, declared on Wednesday the resignation of Larry Wise as president, effective as of 1 October 2009. A In conjunction, the company announced the appointment of James G. Borem as president and interim chief financial officer. A Previously, Borem was employed in senior management positions with Sun Oil, Eastern Pipeline Company, Andover Oil Company, Vintage Petroleum, Latex Resources, Double Eagle Petroleum and Comanche Energy. A Shane Broesky will also step down as the company's chief financial officer but will remain as a director and Sharon Farris has resigned as a director.

----------------------------------------------------------------- ----------------------------------------------------------------- --------------------------

(NASDAQ: XOM) Exxon Mobil Corp.

BREAKING NEWS!!

ExxonMobil Chemical Demonstrates Technology Leadership at Rubber Expo 2009

HOUSTON, Oct 07, 2009 -- ExxonMobil Chemical will showcase its ongoing commitment and technology leadership to the global rubber industry at The Rubber Expo(TM) in Pittsburgh, PA from October 13-15, 2009. The company offers the rubber industry a broad portfolio of polymer solutions, including specialty elastomers, polymer modifiers (PM) and butyl polymers. At the conference, ExxonMobil Chemical will make a number of presentations that demonstrate its technology expertise across this product portfolio.

Three presentations will highlight ExxonMobil Chemical's 40 years of expertise in EP(D)M(2) technology. Topics covered in the presentations include:

-- Metallocene EPDM polymers with enhanced low temperature performance

-- Comparisons of conventional and metallocene EP(D)M elastomers, and their binary blends, designed for low voltage (LV) and medium voltage (MV) cable insulation

-- An overview of polymerization processes for the manufacture of conventional and metallocene EPDM polymers.

One of the largest producers of metallocene and conventional EP(D)M elastomers in the world, ExxonMobil Chemical is expanding its performance capabilities with the introduction of new EPDM grades. These will be targeted at a variety of low temperature, molded and extruded applications, including weatherseals and hose.

To effectively supply increasing demand for Vistalon(TM) EPDM and support the expansion of its product portfolio, ExxonMobil Chemical is adding capacity in Singapore, which includes a 300,000 tons per year elastomers unit. Start-up is expected in 2011.

ExxonMobil Chemical also will feature its wide range of Elevast(TM) polymer modifiers (PM) at The Rubber Expo (booth number 1639). Elevast PM are specialty hydrocarbon fluids that improve mechanical properties across an extended range of service temperatures for applications ranging from wire and cable to automotive and industrial belts, weatherstrip, hoses and mechanical goods such as seals, gaskets and wiper blades.

The EPDM presentations will take place in the David L. Lawrence Convention Center, as follows:

Tuesday, October 13, 2009: 9:00am

"Amorphous Metallocene EPDM for Superior Low Temperature Properties" reviews the recent advances in metallocene solution polymerization and will compare the physical properties of amorphous EPDM prepared by metallocene technology and conventional Ziegler Natta methods. Results indicate that polymers with uniform compositional distribution and low ethylene content prepared by metallocene catalysts offer a balance of mechanical properties and low temperature elastic properties.

Wednesday, October 14, 2009: 8:30am

"Insulation Compounds Made From Vistalon(TM) EP(D)M Polymers" compares conventional EP(D)M elastomers, metallocene EP(D)M elastomers and their binary blends in filled compounds designed for low voltage (LV) and medium voltage (MV) cable insulation. Key performance attributes such as cure characteristics, physical properties, heat-aged physical properties and wet electrical properties are discussed.

Wednesday, October 14, 2009: 3:45pm

"EPDM - Past, Present and Future" provides a comparison of the processes used to make EPDM with Ziegler-Natta catalysts and metallocene catalysts. The range of products produced between these two platforms will be discussed, highlighting the influence of process chosen on energy efficiency versus the breadth of product characteristics.

About ExxonMobil Chemical

ExxonMobil Chemical is one of the world's premier petrochemical companies with manufacturing, technology, and marketing operations around the world. The company delivers a broad portfolio of products and solutions efficiently and responsibly, with a commitment to create outstanding customer and shareholder value. ExxonMobil Chemical endorses the principles of sustainable development, including the need to balance economic growth, social development and environmental considerations. To learn more, visit www.exxonmobilchemical.com.

Note to Editors:

1. The terms, "we," "our," "ExxonMobil Chemical," or "ExxonMobil" are used for convenience, and may include any one or more of ExxonMobil Chemical Company, Exxon Mobil Corporation, or any affiliates they directly or indirectly steward. ExxonMobil, the ExxonMobil Logo, the Interlocking "X" Device, Vistalon and Elevast are trademarks of ExxonMobil.

2. EPDM (ethylene propylene diene monomer (terpolymer).

SOURCE: ExxonMobil Chemical

----------------------------------------------------------------- ----------------------------------------------------------------- --------------------------

(NYSE: NOC) Northrop Grumman Corp.

BREAKING NEWS!!

Photo Release -- Northrop Grumman Names Stephen D. Hogan Vice President, Information Operations and Electronic Attack

BETHPAGE, N.Y., Oct 7, 2009 -- Northrop Grumman Corporation (NYSE:NOC) has named Stephen D. Hogan vice president of Information Operations and Electronic Attack and Integrated Product Team leader for the company's Aerospace Systems sector.

As the team leader, Hogan will be responsible for directing approximately 600 employees working in Bethpage, N.Y., St. Augustine, Fla., Hollywood, Md., and Camarillo, Calif. The portfolio of the Information Operations and Electronic Attack IPT includes the Improved Capability III airborne electronic attack (AEA) system in the EA-6B Prowler and its derivative in the EA-18G Growler, the company's Next Generation Jammer (NGJ) offering, and advanced decision support and targeting software tools such as RainStorm(TM) and the Net-centric Enabled Mission eXecution System (NEMXS(TM)).

Prior to his promotion, Hogan was program director and capture lead for the company's NGJ program. He was responsible to win and execute all NGJ related contracts and development activities, as well as pursuing follow-on opportunities for the NGJ and its associated technologies.

Hogan previously led the Northrop Grumman team responsible for developing the AEA system that is the heart of the EA-18G. The EA-18G United States Navy-Boeing-Northrop Grumman team introduced this advanced AEA system to the fleet on time and under budget. For their efforts, the team was awarded the 2008 NAVAIR Commander's Award. Hogan also has won several management awards in his own right.

Before joining Northrop Grumman, Hogan had held program and acquisition management positions within the U. S. Department of the Navy.

He earned a Bachelor of Science degree in mechanical engineering from University of Maryland, a master's degree in engineering administration from George Washington University and is a certified program management professional.

(Photo: http://www.primezone.com/newsroom/prs/?pkgid=)

Northrop Grumman Corporation is a leading global security company whose 120,000 employees provide innovative systems, products, and solutions in aerospace, electronics, information systems, shipbuilding and technical services to government and commercial customers worldwide.

----------------------------------------------------------------- ----------------------------------------------------------------- --------------------------

About StockMarketingInc.com

StockMarketingInc.com is a website that profiles stocks of interest. We are not licensed brokers or financial consultants.

The information here is believed to be reliable, but not guaranteed to be accurate by tockMarketingInc.com. Please be advised that the information contained may or may not be complete and is solely for informational purposes only. This is not to be construed as an offer to sell, hold or the solicitation of an offer to buy. Investors are encouraged to seek opinions by their registered brokers or financial advisors after extensive due diligence is performed.

CONTACT: StockMarketingInc.com Tel: +1 866 583 8960 e-mail: info@StockMarketingInc.com WWW: http://www.StockMarketingInc.com

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

Related terms: academic, acquisition, aerospace, agriculture, anthrax, automotive, bank, banking, biology, biomedical, biotechnology, budget, business, california, cancer, ceo, clinical, commerce, commercial, consulting, corporate, defense, disease, dna, economic growth, editors, electrical, electronics, email, e-mail, energy, energy efficiency, engineering, equity, exploration, florida, forecasts, frankfurt, gasoline, government, grants, hardware, health, homeland security, industrial, investment, investment opinion, legal, manufacturing, market, marketing, maryland, massachusetts, mechanical engineering, media, medicine, military, nasa, nasdaq, natural gas, navy, north korea, note, nyse, oil, oil and gas, petroleum, pharmaceuticals, physicians, pipeline, president, products, research, research and development, resignation, rubber, sales, science, securities, security, singapore, software, south korea, species, technology, training, united states, university, washington, weapons, web, wyoming